> ## Content Index
> Fetch the complete content index at: https://www.theinvestornarrative.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# When a VC Fund Falters, What Happens to the Companies It Backed?
- URL: https://www.theinvestornarrative.com/when-a-vc-fund-falters/
- Published: 2026-08-26T21:07:00.000Z
- Updated: 2026-10-02T23:44:38.000Z
- Description: A healthy company can inherit financing, governance, and cap-table risk when a major investor falters. Here’s what can change—and how boards can prepare before someone else’s crisis reaches the company.
- Author: Tom Krutilek
- Tags: Board Judgment

*A healthy company can inherit financing, governance, and cap-table problems from an investor whose circumstances change. Here’s what happens when a venture fund winds down, loses key people, or becomes a forced seller—and what boards can do before it happens.*

## **In brief**

- A company does not have to falter for its cap table to become a problem. When an investor winds down, loses key people, faces misconduct or insolvency, or becomes a forced seller, fund-level problems can migrate directly into the company’s financing and governance.
- The shares usually remain. What can change is who manages them, whether follow-on capital remains available, who controls board and voting rights, and whether the stake is sold. The answer depends on the fund’s structure, governing documents, and what went wrong.
- Boards should treat major investors as capital counterparties—not just permanent names on the cap table. An *Investor Continuity Review* can identify where the company depends on one investor and what alternatives exist if that investor can no longer perform the role the company expected.

---

Late one night this past July, major ownership stakes in several private AI companies were being shopped in a room their founders weren't in.

Facing a cascade of margin calls, Leopold Aschenbrenner—the former OpenAI researcher whose hedge fund, Situational Awareness, had grown to roughly $45 billion—was trying to raise cash any way he could. He approached Sequoia Capital and Greenoaks about buying private stakes, including a reported $3.5 billion slice of his position in Anthropic. That sale fell through. Before the market opened, Ken Griffin's Citadel bought the bulk of the fund's public portfolio at a reported discount of more than 10%; Aschenbrenner repaid his lenders, and the private stakes were spared. The fund survived—down 67% for the month, its leverage gone —though its *private positions* in Anthropic, Fluidstack, and MatX remained intact.

*Read that from the founder's chair.* The companies whose shares nearly changed hands had done nothing wrong—they hit no wall and missed no number. They simply sat on the balance sheet of a fund under pressure, and for a few hours, whether a major stake in each of them changed hands under distress was being decided by other people, in another building, as a solution to someone else's problem.

The margin call stopped short of the cap table this time—though the SEC has since subpoenaed the fund's lenders over its trades and leverage, and the fund has not been accused of wrongdoing. But the near-miss exposes a risk most founders never price: *what happens to a healthy company when the fund behind it falters.*

Situational Awareness is a hedge fund, not a venture fund—traditional VC funds generally don't run leveraged public-equity portfolios, so they rarely face this exact trigger. But once a fund's troubles reach its private holdings, the question for those companies is the same one a faltering VC creates: who might own and control these shares next?

> ***This time, the margin call stopped short of the cap table. The next one may not.***

## **Why the risk is invisible**

Founders conduct diligence on almost everyone they let near the business—customers, key hires, the other investors in a syndicate—then take a fund's capital and treat it as settled rather than the start of a relationship with a counterparty that has its own solvency, structure, and clock. That's the blind spot, and it has two faces: whether an investor can still fund you, and who exercises its rights over your company if something changes at the fund.

> ***Investor concentration is counterparty risk—and most cap tables have never planned for it.***

## **A fund can falter in many ways—and each plays out differently**

*Fund trouble does not follow a single path*. A venture fund can wind down voluntarily, lose key partners, become entangled in misconduct, get caught in a parent company's bankruptcy, lose access to capital from a major limited partner, or come under pressure to sell investments. The form of the problem matters because it determines what can change for the companies the fund backed.

A fund can wind down in an orderly way, as Countdown Capital did in early 2024—honoring its existing commitments, releasing capital it had not yet called, and continuing to manage its remaining investments. It can lose the partners who drove it: when two of OpenView's three leaders left in 2023, months after it closed a $570 million fund, the firm halted new investments, cut most of its staff, and continued to manage existing portfolio companies while preserving reserves for follow-on support. It can unravel over misconduct. It can be pulled into a parent company's bankruptcy. It can be starved of expected capital by a dominant limited partner. Or it can come under pressure to sell assets to raise cash, as Situational Awareness nearly did with its private holdings.

Beneath all of those scenarios sits the distinction that matters most: the venture firm, the fund, the general partner, the investment manager, and the individual partner on your board are not the same entity. The fund typically owns the shares. The GP controls the fund under the limited partnership agreement. A manager and its people handle the day-to-day investment work. An individual partner may occupy a board seat—but the contractual right to choose who fills it may belong to the fund, the GP, the manager, or another affiliated entity.

When trouble reaches one part of that structure, the rest do not automatically disappear. What can change is who has authority over the stake, what that party is permitted to do, and whether the investor can continue playing the financing and governance role the company expected. The answer depends on what happened at the fund—and on the governing documents.

> ***The shares may remain. The investor relationship may not.***

## **Who Controls the Stake When the Manager Falters?**

Consider three cases, each answering a different question.

**What happens to the board seat?** When Binary Capital's co-founder resigned amid a 2017 harassment scandal, the firm unraveled within days. Its limited partners moved to wind down the barely deployed second fund, while portfolio companies sought to terminate Binary's board relationships or buy back its shares. Management of the debut fund—and responsibility for its portfolio relationships—ultimately moved to Lerer Hippeau, an early-stage venture capital firm, giving the companies a new investment manager to work with.

**Can the portfolio outlive its manager?** Yes. After the SEC charged Michael Rothenberg with misappropriating investor money in 2018—a case that later produced a court order to pay more than $31 million—his firm's portfolio survived. Force 10 Partners was brought in to administer funds holding more than 100 investments, including Robinhood, SpaceX, and Patreon, and steer the positions toward distributions. The manager failed; the assets were stewarded by someone new.

**Can control shift when the problem starts with an LP?** Apple Tree Partners, a life-sciences VC, drew the vast majority of its capital—reportedly around 98%—from a single limited partner, the family office of a Russian billionaire. When a dispute with that backer choked off funding for roughly eighteen months, an "existential" liquidity crisis spread across portfolio biotechs. Litigation followed on two continents, and a court moved to strip the general partner of control. The fund's assets still dwarfed its debts; the crisis originated one layer up, in the investor it depended on.

The variations extend further. When FTX collapsed, its venture stakes entered a bankruptcy estate that, with court approval, sold its Anthropic position for about $1.3 billion to pay creditors. When Silicon Valley Bank's parent failed, its investment arm was sold intact to a new sponsor. Different circumstances, different answers to the same question: *who controls the shares now?*

## **What actually lands on the company**

Whatever the path, the fallout tends to arrive through the same four doors.

**Governance goes quiet.** The investor's board seat empties, or passes to a fiduciary who understands the balance sheet but not the business. Quorum for a financing or an acquisition can stall while everyone waits to learn who now holds the vote.

**Follow-on evaporates.** A distressed or frozen fund may write zero into your next round, and when the insider who knows you best sits out, outside investors read it as a signal unless you get ahead of the narrative. For many companies, this is the existential risk—losing a board member is survivable; losing the investor expected to lead the next round may not be.

**The stake can be sold over your head.** A forced seller may move the position at a discount to a buyer you didn't choose and wouldn't have—one whose objectives may not be yours. Transfer restrictions and rights of first refusal give the company some say over who joins the cap table, but only if they were written to—and only if someone is willing to buy. In bankruptcy, however, some transfer restrictions may not provide the protection the company expected, depending on the circumstances and applicable law.

**Your information travels.** In bankruptcy, metrics and cap-table details you consider confidential can surface in public filings.

> ***A distressed fund doesn't just stop helping—it can become a seller, a vacancy, or a veto.***

## **The board's response: an Investor Continuity Review**

None of this calls for alarm. It calls for the same discipline good boards already apply to every other concentration risk—made standing and written down.

Call it an *Investor Continuity Review*—a standing, board-led assessment of how much the company depends on any single investor, and what happens to its financing and governance if that investor can no longer perform. It is the company examining its investors, not a fund examining its own LPs. Run it annually and whenever an investor's circumstances change, and make it produce written answers to a handful of questions. 

- How dependent are we on any single investor for our next round, a bridge, or board leadership?
- Which investors actually have reserves for follow-on, versus merely pro-rata rights—remembering that a reserve or a pro-rata right is an option to invest, never a promise?
- Who holds the contractual right to designate or replace each investor-appointed director if the current partner departs?
- What transfer restrictions and rights of first refusal apply if a major holder sells?
- Which of our investors' funds are late in their life or facing a known key-person transition?
- And if our lead investor stopped participating tomorrow, who else on or near our cap table could credibly step into its capital and governance role?

Some of these you can answer from your own agreements; others you'll have to ask your investors directly. *The point isn't to distrust anyone—it's to find the single points of failure before one fails.*

Two structural moves make the review real. *First*, seat genuinely independent directors—the kind whose incentives track the company's timeline rather than any one fund's. When a fund's distress starts pulling at decisions, they give the board a disinterested voice and a cleaner path to acting in the company's interest rather than any single investor's. *Second*, remember that for a typical Delaware corporation, an investor-appointed director owes fiduciary duties to the company and its stockholders as a whole, not only to the fund that nominated them. A fund's problems do not automatically become the board's marching orders.

Exactly how any of this plays out is specific to the fund's governing documents and your own agreements. But the recognition behind it is general: capital-provider risk is real, and when it materializes, it migrates straight onto your cap table.

## **Summary**

A fund can falter in many ways, and each can change who manages its stakes—or simply leave the investor unable to provide the capital, governance, or support the company expected. The shares usually survive. The investor relationship may not.

Boards that map who holds the rights behind each major stake, understand what happens if an investor can no longer perform, and maintain genuinely independent governance are less likely to discover those dependencies in the middle of someone else’s crisis.

In a market defined by capital concentration, aging funds, and uneven liquidity, this is not an exotic risk. It is a structural one.

---

## **References**

- [Bloomberg News — Hema Parmar and Natasha Mascarenhas, “Aschenbrenner Tried to Sell Private Stakes Before Stock Deal,” July 31, 2026.](https://news.bloomberglaw.com/private-equity/aschenbrenner-tried-to-sell-private-stakes-before-citadel-deal?ref=theinvestornarrative.com)
- [Reuters — “Situational Awareness’ Portfolio Sinks 67% in July on AI Stock Rout, Letter Shows,” July 31, 2026.](https://www.reuters.com/business/finance/situational-awareness-portfolio-sinks-67-july-ai-stock-rout-letter-shows-2026-07-31/?ref=theinvestornarrative.com)
- [Reuters — “Ken Griffin’s Citadel Sheds Over 80% of Situational Awareness’ Bets,” August 21, 2026.](https://www.reuters.com/markets/wealth/citadel-sheds-over-80-aggregate-risk-situational-awareness-portfolio-2026-08-21?ref=theinvestornarrative.com)
- [Reuters — “US SEC Subpoenas Wall Street Lenders Over Situational Awareness Meltdown, Source Says,” August 24, 2026.](https://www.reuters.com/legal/government/us-sec-sends-subpoenas-wall-street-banks-over-situational-awareness-nyt-reports-2026-08-24?ref=theinvestornarrative.com)
- [TechCrunch — Aria Alamalhodaei, “Early-Stage Hard Tech Firm Countdown Capital Shutting Down,” January 2, 2024.](https://techcrunch.com/2024/01/02/early-stage-hard-tech-firm-countdown-capital-shutting-down?ref=theinvestornarrative.com)
- [Axios — Dan Primack, “OpenView Venture Partners Stops Investing, in Surprise Move,” December 6, 2023.](https://www.axios.com/2023/12/06/openview-venture-partners-stops-investing?ref=theinvestornarrative.com)
- [TechCrunch — Connie Loizos, “Lerer Hippeau Is Taking Over Management of Binary Capital’s Debut Fund,” March 26, 2018.](https://techcrunch.com/2018/03/26/lerer-hippeau-ventures-is-taking-over-management-of-binary-capitals-debut-fund?ref=theinvestornarrative.com)
- [U.S. Securities and Exchange Commission — “Court Orders Technology Fund Adviser to Pay More Than $31 Million,” Litigation Release No. 24714, January 13, 2020.](https://www.sec.gov/enforcement-litigation/litigation-releases/lr-24714?ref=theinvestornarrative.com)
- [Force 10 Partners — “Rothenberg Ventures — Venture Capital Fund Management.”](https://www.force10partners.com/engagement/rothenberg-ventures?ref=theinvestornarrative.com)
- [Delaware Court of Chancery — ATP III GP, Ltd. v. Rigmora Biotech Investor One LP, et al. (2025).](https://courts.delaware.gov/Opinions/Download.aspx?id=388390&ref=theinvestornarrative.com)

#BoardGovernance #VentureCapital #CapTable #CapitalReadiness #Liquidity #InvestorRelations

## **About the Author**

*Tom Krutilek is a Board Advisor and Chief Marketing Officer who works with early-stage and growth-stage companies on capital readiness, investor narrative, go-to-market strategy, and AI strategy and governance. His work focuses on a central question: whether growth is truly investable—not just impressive on paper.*

*He helps founders, CEOs, and boards connect commercial performance, capital strategy, and execution to the evidence investors need to underwrite growth. That includes strengthening the investor narrative, identifying gaps in capital readiness, building measurable growth systems, and evaluating where AI can create durable business value and competitive advantage.*

*Tom is also the founder of The Investor Narrative, a publication focused on private capital markets from the perspective of investor readiness. It examines the questions behind the headline numbers—how investors assess growth, capital efficiency, demand quality, competitive advantage, governance, and the assumptions that ultimately determine whether a company is ready for investment capital.*

[Connect with Tom on LinkedIn](https://www.linkedin.com/in/tom-krutilek/?ref=theinvestornarrative.com)